Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Syneron raises $150m for macrocyclics, and other financings

 April 9, 2026

Pharmaphorum

Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.

M&A / DealsRead full story

Post navigation

Shionogi secures $482m BARDA contract to tackle AMR crisis →
← FDA seeks permanent future for rare pediatric priority review vouchers

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com